The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processesfor their preparation, to their use alone or in combinations for the treatmentand/or prophylaxis ofdiseases, and to their use for producing medicaments for the treatment and/orprophylaxis ofdiseases, in particular for the treatment and/or prophylaxis of cardiovasculardisorders.